How much does a box of crizotinib cost?

Crizotinib is a targeted therapy drug mainly used to treat ALK (anaplastic lymphoma kinase) gene rearrangement-positive non-small cell lung cancer (NSCLC). It prevents the growth and spread of cancer cells by inhibiting the abnormal activity of ALK and ROS1 genes. Crizotinib is a first-generation ALK inhibitor. As a targeted therapy, it has more precise efficacy and fewer side effects than traditional chemotherapy. The therapeutic effect of crizotinib has been verified in multiple clinical trials and is one of the important treatment options for patients with ALK-positive non-small cell lung cancer.

Crizotinib is currently on the market in China and has been included in medical insurance. Patients can purchase this medication through the hospital pharmacy. The specific price will vary depending on the region and hospital, but is usually around four to five thousand yuan. Due to different medical insurance policies in different places, patients can reimburse part of the cost through medical insurance when purchasing. For specific reimbursement information, they should consult the local hospital pharmacy or medical insurance bureau.

In addition, the purchase channels for crizotinib abroad mainly include original drugs and generic drugs. Original drugs are usually produced by Pfizer (Pfizer) and are relatively expensive, about 10,000 yuan. Pfizer's original drugs have high standards in terms of drug ingredients and efficacy and are widely used clinically.

The price of generic drugs is relatively cheap, mainly produced by pharmaceutical factories in Bangladesh and Laos, and the price is generally around one to two thousand yuan. Although the price of these generic drugs is lower, their drug ingredients are basically the same as the original drugs, and they have been certified by international drug regulatory agencies, so their quality and efficacy can be guaranteed. Therefore, generic drugs are the first choice for many patients, especially those who have higher requirements on drug costs.

Crizotinib is already on the market in China and is included in medical insurance, and patients can purchase it through regular hospital pharmacies. The prices of original drugs and generic drugs are different. Patients can choose suitable drugs according to their personal circumstances, and consult the relevant prices and medical insurance reimbursement policies when purchasing.